Skip to main content
Priscilla Furth, MD, Infectious Disease, Washington, DC, MedStar Georgetown University Hospital

PriscillaFurthMD

Infectious Disease Washington, DC

Professor, Associate Dean, Medical Center; Professor, Lombardi Comprehensive Cancer Center (LCCC), GUMC Faculty Affairs, Georgetown University Hospital

Are you Dr. Furth?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 26 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Priscilla Furth, MD is an infectious disease specialist in Washington, District of Columbia. She is currently licensed to practice medicine in District of Columbia and Maryland. She is affiliated with MedStar Georgetown University Hospital and is a Professor at Medical Center; Professor.

Education & Training

  • Yale School of Medicine
    Yale School of MedicineClass of 1979
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Infectious Disease

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1985 - 2024
  • DC State Medical License
    DC State Medical License 2002 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Breast Cancer’s Prognostic Toolkit Expands for Post-Menopausal Women
    Breast Cancer’s Prognostic Toolkit Expands for Post-Menopausal WomenDecember 1st, 2022
  • Study in Mice Suggests That Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention Strategies
    Study in Mice Suggests That Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention StrategiesDecember 1st, 2022
  • Health News | Researchers Discover New Approach to Detect Early Signs of Breast Cancer
    Health News | Researchers Discover New Approach to Detect Early Signs of Breast CancerSeptember 14th, 2022
  • Join now to see all

Grant Support

  • Mechanisms Regulating Reversal Of MalignancyNational Cancer Institute2006–2009
  • Progression And Regression Of Mammary PreneoplasiaNational Cancer Institute2005–2009
  • Mechanisms Regulating Reversal Of PremalignancyNational Cancer Institute2001–2005
  • Mechanisms Regulating Reversal Of PremalignancyNational Cancer Institute2001
  • BCL-2 Gene Family, Apoptosis Resistance And Breast CanceNational Cancer Institute1996–2000
  • BCL-2 Gene Family, Apoptosis Resistance &Breast CancerNational Cancer Institute1998–1999
  • BCL2 Gene Family, Apoptosis Resistance And Breast CanceNational Cancer Institute1998
  • Hormonal Effects On Apoptosis In Breast CancerNational Cancer Institute1995–1996

Professional Memberships

Hospital Affiliations